J&J asks FDA to clear booster dose of its coronavirus vaccine
The agency is holding an advisory committee meeting on Oct. 15 to discuss a second dose of J&J’s shot, as well as boosting with different vaccines.
The agency is holding an advisory committee meeting on Oct. 15 to discuss a second dose of J&J’s shot, as well as boosting with different vaccines.
After 12 years in the top job, the veteran director says a new scientist should assume leadership of the world’s largest biomedical research institution.
Overall deal volume decreased, though, with 169 deals in Q3 compared to 223 deals in Q2. The third quarter also saw fewer megadeals of $100 million or above.
Cigna, UnitedHealth and Centene are all entering new areas for 2022, but analysts say benefit options show that bids from insurers are relatively conservative.
“This is a chance to take a hard look and see if it’s worth it. The document may signal that some types of practices are just too risky,” said Ben Wallfisch, a senior counsel with the Office of Counsel to the HHS Inspector General.
Allowed in-network charges for fixed-wing air ambulances rose 76.4% between 2017 and 2020, and now top $15,000, a new study by Fair Health found.
Industry reached a “watershed moment” earlier this year when a device outage caused by malware endangered patient lives, Kevin Fu, acting director of cybersecurity at CDRH said. “That was something we haven’t seen before.”
Dr. J. Allen Meadows worked with Teva Pharmaceuticals to share his experience with the Digihaler® family of inhalers and accompanying platforms.
Poor “cognitive ergonomics” adds to physician overload, affecting well-being and quality of care
Analysts said that after reviewing benefits for the three largest plans from top insurers, it saw stability to modest improvements, indicating conservative bids among the uncertainty of the COVID-19 pandemic.